# levothyroxine sodium

NDC: 68071-5235
Generic name: levothyroxine sodium
Labeler / Manufacturer: NuCar Pharmaceuticals,Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20190507

FDA application: NDA021116

## Active ingredients

- LEVOTHYROXINE SODIUM: 100 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68071-5235"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68071-5235
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a2194c58-b755-e6b5-e053-2a95a90a36d4